AZD9833 China PK Study

Clinical trial NCT04818632 · COMPLETED

Trial details

NCT number: NCT04818632
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

ER+, HER2-, Metastatic Breast Cancer

Start date: 2021-11-12
Primary completion: 2023-09-07
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.